- Correction
- Open access
- Published:
Correction to: Carriage of distinct blaKPC-2 and blaOXA-48 plasmids in a single ST11 hypervirulent Klebsiella pneumoniae isolate in Egypt
BMC Genomics volume 23, Article number: 270 (2022)
Correction to: BMC Genomics 23, 20 (2022)
https://doi.org/10.1186/s12864-021-08214-9
Following publication of the original article [1], it was reported that there was an error in the presentation of Lin Xu and Guo-Bao Tian’s affiliations in the PDF version of the article. Furthermore, the authors reported a typographical error in the sub-section ‘Antimicrobial susceptibility testing’. The correction is highlighted in bold.
The incorrect sentence was:
“Minimum inhibitory concentrations (MICs) were determined for the following 17 diferent antibiotics: cefotaxime (CTX), ceftazidime (CAZ), cefepime (FEP), colistin (CT), tigecycline (TGC), imipenem (IMP), ertapenem (ETP), meropenem (MEM), ciprofoxacin (CIP), fosfomycin (FOS), trimethoprim-sulfamethoxazole (SXT), piperacillin-tazobactam (PTZ), amikacin (AMK), gentamicin (GEN), chloramphenicol (CHL), tetracycline [5], and aztreonam (ATM) for EBSI041 using the agar microdilution method excepted for colistin using the broth microdilution method.”
The correct sentence is:
Minimum inhibitory concentrations (MICs) were determined for the following 17 diferent antibiotics: cefotaxime (CTX), ceftazidime (CAZ), cefepime (FEP), colistin (CT), tigecycline (TGC), imipenem (IMP), ertapenem (ETP), meropenem (MEM), ciprofoxacin (CIP), fosfomycin (FOS), trimethoprim-sulfamethoxazole (SXT), piperacillin-tazobactam (PTZ), amikacin (AMK), gentamicin (GEN), chloramphenicol (CHL), tetracycline (TET), and aztreonam (ATM) for EBSI041 using the agar microdilution method excepted for colistin using the broth microdilution method.
The correct affiliations presentation is given in this Correction article and the original article [1] has been updated.
Reference
Yang Y, Yang Y, Ahmed MAEGES, et al. Carriage of distinct blaKPC-2 and blaOXA-48 plasmids in a single ST11 hypervirulent Klebsiella pneumoniae isolate in Egypt. BMC Genomics. 2022;23:20. https://doi.org/10.1186/s12864-021-08214-9.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yang, Y., Yang, Y., Ahmed, M.A.EG.ES. et al. Correction to: Carriage of distinct blaKPC-2 and blaOXA-48 plasmids in a single ST11 hypervirulent Klebsiella pneumoniae isolate in Egypt. BMC Genomics 23, 270 (2022). https://doi.org/10.1186/s12864-022-08477-w
Published:
DOI: https://doi.org/10.1186/s12864-022-08477-w